1 | therapeutic | 28,190 |
2 | therapeutical | 251 |
3 | immunotherapeutic | 116 |
4 | thromboprophylactic | 35 |
5 | bowel-cleansing | 19 |
6 | transulnar | 17 |
7 | theranostic | 14 |
8 | anhidrotic | 10 |
9 | blood-saving | 10 |
10 | theraputic | 8 |
11 | bias-reducing | 7 |
12 | surgery-sparing | 7 |
13 | hba1c-lowering | 6 |
14 | larynx-preservation | 6 |
15 | multi-model | 6 |
16 | multi-sectoral | 6 |
17 | seizure-inducing | 6 |
18 | values-based | 6 |
19 | biomarker-integrated | 5 |
20 | chemo-preventive | 5 |
21 | cloud-based | 5 |
22 | disease-prevention | 5 |
23 | non-approved | 5 |
24 | preventive/therapeutic | 5 |
25 | 'dual | 4 |
26 | anti-pancreatic | 4 |
27 | client-oriented | 4 |
28 | homeorhetic | 4 |
29 | immunotherapeutical | 4 |
30 | least-cost | 4 |
31 | lipid-atherosclerosis | 4 |
32 | paratransgenic | 4 |
33 | personality-specific | 4 |
34 | postvention | 4 |
35 | afterload-reducing | 3 |
36 | applicative | 3 |
37 | client-therapist | 3 |
38 | combination-treatment | 3 |
39 | diagnostic/prognostic | 3 |
40 | guideline-specified | 3 |
41 | health-coping | 3 |
42 | hypervolaemic | 3 |
43 | near-absolute | 3 |
44 | parent-therapist | 3 |
45 | previously-reported | 3 |
46 | prophylactic/therapeutic | 3 |
47 | sleep-enabling | 3 |
48 | tumor-driven | 3 |
49 | academic-practice | 2 |
50 | akt/mammalian | 2 |
51 | biotechnologic | 2 |
52 | bp/ldl-c | 2 |
53 | caries-inhibition | 2 |
54 | clinical/bacteriological | 2 |
55 | cni-sparing | 2 |
56 | cost-control | 2 |
57 | disease-treatment | 2 |
58 | fertility-preservation | 2 |
59 | intervenient | 2 |
60 | land-sparing | 2 |
61 | less-traditional | 2 |
62 | limited-duration | 2 |
63 | mri-planned | 2 |
64 | nanotherapeutic | 2 |
65 | non-tki | 2 |
66 | nucleoside-sparing | 2 |
67 | patient-inclusion | 2 |
68 | photoantimicrobial | 2 |
69 | pka-shift | 2 |
70 | population-directed | 2 |
71 | radiologist-based | 2 |
72 | review.transcervical | 2 |
73 | soccer-training | 2 |
74 | therapist-level | 2 |
75 | theraupeutic | 2 |
76 | trust-based | 2 |
77 | youth-therapist | 2 |
78 | 'conscious | 1 |
79 | 'wide-field | 1 |
80 | 172,754 | 1 |
81 | 21-min | 1 |
82 | 400-microgram | 1 |
83 | 600-microg | 1 |
84 | a.potential | 1 |
85 | adenosine-regulating | 1 |
86 | adherence-modifying | 1 |
87 | adiponectin/resistin | 1 |
88 | aesthetic-laser-surgical | 1 |
89 | akt-mammalian | 1 |
90 | altered-self | 1 |
91 | anticoagulant-based | 1 |
92 | antieosinophil | 1 |
93 | antipyrectic | 1 |
94 | antiretrovirological | 1 |
95 | autoantibody-based | 1 |
96 | biofortified-maize | 1 |
97 | biomaterial-based | 1 |
98 | biomechanistic | 1 |
99 | blood-management | 1 |
100 | buddhism-based | 1 |
101 | capstrep±cis | 1 |
102 | cell-therapy | 1 |
103 | complement-blocking | 1 |
104 | compound-protein | 1 |
105 | conservation-friendly | 1 |
106 | cost-diagnostic | 1 |
107 | cost-reduction | 1 |
108 | csc-targeting | 1 |
109 | cu-free | 1 |
110 | cytomic | 1 |
111 | dia-gnostic | 1 |
112 | disease-antiarrhythmic | 1 |
113 | effectsagainst | 1 |
114 | gaba-based | 1 |
115 | gender-oriented | 1 |
116 | gsα | 1 |
117 | gvhd-like | 1 |
118 | gzo | 1 |
119 | haemorrhage.the | 1 |
120 | havcr/kim-1-related | 1 |
121 | hdc-based | 1 |
122 | high-carbon-yield | 1 |
123 | higher-weighted | 1 |
124 | human-health | 1 |
125 | hyperciholesterolemia | 1 |
126 | hypnotic-anaesthetic | 1 |
127 | hypoxia-relevant | 1 |
128 | immunomodulatory/cytotoxic | 1 |
129 | internet/telephone-based | 1 |
130 | intertube | 1 |
131 | laborsaving | 1 |
132 | later-appearing | 1 |
133 | leaders‟ | 1 |
134 | lower-weighted | 1 |
135 | management/treatment | 1 |
136 | mechanistic/therapeutic | 1 |
137 | mechanostimulatory | 1 |
138 | medication/fluid | 1 |
139 | neurolipidomic | 1 |
140 | non-curriculum | 1 |
141 | non-gradient-based | 1 |
142 | non-psychostimulant | 1 |
143 | nonhormone-based | 1 |
144 | o-functionalized | 1 |
145 | on-boarding | 1 |
146 | pain-regulation | 1 |
147 | parenting-based | 1 |
148 | patient-counselor | 1 |
149 | phenotype/syndrome-driven | 1 |
150 | pi3k/mammalian | 1 |
151 | post-iph | 1 |
152 | previewed | 1 |
153 | prognosis.treatment | 1 |
154 | psychiatrist/caregiver/patient | 1 |
155 | radio-frequency-based | 1 |
156 | radiochemotherpeutic | 1 |
157 | resource-conscious | 1 |
158 | rsabe | 1 |
159 | safe-transport | 1 |
160 | searched-for | 1 |
161 | semi-subjective | 1 |
162 | sleep-pharmacogenetic | 1 |
163 | splenectomy-avoiding | 1 |
164 | statin-specific | 1 |
165 | stent-mediated | 1 |
166 | study.treatment | 1 |
167 | sublingual/swallow | 1 |
168 | subordinate-male | 1 |
169 | symbiont-based | 1 |
170 | thrombopoietic-stimulating | 1 |
171 | topical-therapeutic | 1 |
172 | touch/movement | 1 |
173 | trans-1,3-disubstituted | 1 |
174 | web-tailored | 1 |
1 | 'conscious | 1 |
2 | 'dual | 4 |
3 | 'wide-field | 1 |
4 | 172,754 | 1 |
5 | 21-min | 1 |
6 | 400-microgram | 1 |
7 | 600-microg | 1 |
8 | a.potential | 1 |
9 | academic-practice | 2 |
10 | adenosine-regulating | 1 |
11 | adherence-modifying | 1 |
12 | adiponectin/resistin | 1 |
13 | aesthetic-laser-surgical | 1 |
14 | afterload-reducing | 3 |
15 | akt-mammalian | 1 |
16 | akt/mammalian | 2 |
17 | altered-self | 1 |
18 | anhidrotic | 10 |
19 | anti-pancreatic | 4 |
20 | anticoagulant-based | 1 |
21 | antieosinophil | 1 |
22 | antipyrectic | 1 |
23 | antiretrovirological | 1 |
24 | applicative | 3 |
25 | autoantibody-based | 1 |
26 | bias-reducing | 7 |
27 | biofortified-maize | 1 |
28 | biomarker-integrated | 5 |
29 | biomaterial-based | 1 |
30 | biomechanistic | 1 |
31 | biotechnologic | 2 |
32 | blood-management | 1 |
33 | blood-saving | 10 |
34 | bowel-cleansing | 19 |
35 | bp/ldl-c | 2 |
36 | buddhism-based | 1 |
37 | capstrep±cis | 1 |
38 | caries-inhibition | 2 |
39 | cell-therapy | 1 |
40 | chemo-preventive | 5 |
41 | client-oriented | 4 |
42 | client-therapist | 3 |
43 | clinical/bacteriological | 2 |
44 | cloud-based | 5 |
45 | cni-sparing | 2 |
46 | combination-treatment | 3 |
47 | complement-blocking | 1 |
48 | compound-protein | 1 |
49 | conservation-friendly | 1 |
50 | cost-control | 2 |
51 | cost-diagnostic | 1 |
52 | cost-reduction | 1 |
53 | csc-targeting | 1 |
54 | cu-free | 1 |
55 | cytomic | 1 |
56 | dia-gnostic | 1 |
57 | diagnostic/prognostic | 3 |
58 | disease-antiarrhythmic | 1 |
59 | disease-prevention | 5 |
60 | disease-treatment | 2 |
61 | effectsagainst | 1 |
62 | fertility-preservation | 2 |
63 | gaba-based | 1 |
64 | gender-oriented | 1 |
65 | gsα | 1 |
66 | guideline-specified | 3 |
67 | gvhd-like | 1 |
68 | gzo | 1 |
69 | haemorrhage.the | 1 |
70 | havcr/kim-1-related | 1 |
71 | hba1c-lowering | 6 |
72 | hdc-based | 1 |
73 | health-coping | 3 |
74 | high-carbon-yield | 1 |
75 | higher-weighted | 1 |
76 | homeorhetic | 4 |
77 | human-health | 1 |
78 | hyperciholesterolemia | 1 |
79 | hypervolaemic | 3 |
80 | hypnotic-anaesthetic | 1 |
81 | hypoxia-relevant | 1 |
82 | immunomodulatory/cytotoxic | 1 |
83 | immunotherapeutic | 116 |
84 | immunotherapeutical | 4 |
85 | internet/telephone-based | 1 |
86 | intertube | 1 |
87 | intervenient | 2 |
88 | laborsaving | 1 |
89 | land-sparing | 2 |
90 | larynx-preservation | 6 |
91 | later-appearing | 1 |
92 | leaders‟ | 1 |
93 | least-cost | 4 |
94 | less-traditional | 2 |
95 | limited-duration | 2 |
96 | lipid-atherosclerosis | 4 |
97 | lower-weighted | 1 |
98 | management/treatment | 1 |
99 | mechanistic/therapeutic | 1 |
100 | mechanostimulatory | 1 |
101 | medication/fluid | 1 |
102 | mri-planned | 2 |
103 | multi-model | 6 |
104 | multi-sectoral | 6 |
105 | nanotherapeutic | 2 |
106 | near-absolute | 3 |
107 | neurolipidomic | 1 |
108 | non-approved | 5 |
109 | non-curriculum | 1 |
110 | non-gradient-based | 1 |
111 | non-psychostimulant | 1 |
112 | non-tki | 2 |
113 | nonhormone-based | 1 |
114 | nucleoside-sparing | 2 |
115 | o-functionalized | 1 |
116 | on-boarding | 1 |
117 | pain-regulation | 1 |
118 | paratransgenic | 4 |
119 | parent-therapist | 3 |
120 | parenting-based | 1 |
121 | patient-counselor | 1 |
122 | patient-inclusion | 2 |
123 | personality-specific | 4 |
124 | phenotype/syndrome-driven | 1 |
125 | photoantimicrobial | 2 |
126 | pi3k/mammalian | 1 |
127 | pka-shift | 2 |
128 | population-directed | 2 |
129 | post-iph | 1 |
130 | postvention | 4 |
131 | preventive/therapeutic | 5 |
132 | previewed | 1 |
133 | previously-reported | 3 |
134 | prognosis.treatment | 1 |
135 | prophylactic/therapeutic | 3 |
136 | psychiatrist/caregiver/patient | 1 |
137 | radio-frequency-based | 1 |
138 | radiochemotherpeutic | 1 |
139 | radiologist-based | 2 |
140 | resource-conscious | 1 |
141 | review.transcervical | 2 |
142 | rsabe | 1 |
143 | safe-transport | 1 |
144 | searched-for | 1 |
145 | seizure-inducing | 6 |
146 | semi-subjective | 1 |
147 | sleep-enabling | 3 |
148 | sleep-pharmacogenetic | 1 |
149 | soccer-training | 2 |
150 | splenectomy-avoiding | 1 |
151 | statin-specific | 1 |
152 | stent-mediated | 1 |
153 | study.treatment | 1 |
154 | sublingual/swallow | 1 |
155 | subordinate-male | 1 |
156 | surgery-sparing | 7 |
157 | symbiont-based | 1 |
158 | theranostic | 14 |
159 | therapeutic | 28,190 |
160 | therapeutical | 251 |
161 | therapist-level | 2 |
162 | theraputic | 8 |
163 | theraupeutic | 2 |
164 | thrombopoietic-stimulating | 1 |
165 | thromboprophylactic | 35 |
166 | topical-therapeutic | 1 |
167 | touch/movement | 1 |
168 | trans-1,3-disubstituted | 1 |
169 | transulnar | 17 |
170 | trust-based | 2 |
171 | tumor-driven | 3 |
172 | values-based | 6 |
173 | web-tailored | 1 |
174 | youth-therapist | 2 |
1 | 172,754 | 1 |
2 | hyperciholesterolemia | 1 |
3 | bp/ldl-c | 2 |
4 | statin-specific | 1 |
5 | personality-specific | 4 |
6 | biotechnologic | 2 |
7 | hypervolaemic | 3 |
8 | disease-antiarrhythmic | 1 |
9 | neurolipidomic | 1 |
10 | cytomic | 1 |
11 | paratransgenic | 4 |
12 | anti-pancreatic | 4 |
13 | thromboprophylactic | 35 |
14 | antipyrectic | 1 |
15 | homeorhetic | 4 |
16 | hypnotic-anaesthetic | 1 |
17 | sleep-pharmacogenetic | 1 |
18 | anhidrotic | 10 |
19 | biomechanistic | 1 |
20 | theranostic | 14 |
21 | dia-gnostic | 1 |
22 | cost-diagnostic | 1 |
23 | diagnostic/prognostic | 3 |
24 | therapeutic | 28,190 |
25 | topical-therapeutic | 1 |
26 | prophylactic/therapeutic | 3 |
27 | mechanistic/therapeutic | 1 |
28 | preventive/therapeutic | 5 |
29 | nanotherapeutic | 2 |
30 | immunotherapeutic | 116 |
31 | radiochemotherpeutic | 1 |
32 | theraupeutic | 2 |
33 | theraputic | 8 |
34 | immunomodulatory/cytotoxic | 1 |
35 | guideline-specified | 3 |
36 | mri-planned | 2 |
37 | web-tailored | 1 |
38 | gaba-based | 1 |
39 | hdc-based | 1 |
40 | cloud-based | 5 |
41 | internet/telephone-based | 1 |
42 | nonhormone-based | 1 |
43 | parenting-based | 1 |
44 | biomaterial-based | 1 |
45 | buddhism-based | 1 |
46 | values-based | 6 |
47 | anticoagulant-based | 1 |
48 | non-gradient-based | 1 |
49 | symbiont-based | 1 |
50 | radiologist-based | 2 |
51 | trust-based | 2 |
52 | radio-frequency-based | 1 |
53 | autoantibody-based | 1 |
54 | stent-mediated | 1 |
55 | havcr/kim-1-related | 1 |
56 | biomarker-integrated | 5 |
57 | population-directed | 2 |
58 | higher-weighted | 1 |
59 | lower-weighted | 1 |
60 | gender-oriented | 1 |
61 | client-oriented | 4 |
62 | previously-reported | 3 |
63 | trans-1,3-disubstituted | 1 |
64 | non-approved | 5 |
65 | previewed | 1 |
66 | o-functionalized | 1 |
67 | medication/fluid | 1 |
68 | 'wide-field | 1 |
69 | high-carbon-yield | 1 |
70 | rsabe | 1 |
71 | intertube | 1 |
72 | academic-practice | 2 |
73 | cu-free | 1 |
74 | haemorrhage.the | 1 |
75 | gvhd-like | 1 |
76 | subordinate-male | 1 |
77 | near-absolute | 3 |
78 | applicative | 3 |
79 | semi-subjective | 1 |
80 | chemo-preventive | 5 |
81 | biofortified-maize | 1 |
82 | altered-self | 1 |
83 | afterload-reducing | 3 |
84 | bias-reducing | 7 |
85 | seizure-inducing | 6 |
86 | splenectomy-avoiding | 1 |
87 | on-boarding | 1 |
88 | complement-blocking | 1 |
89 | sleep-enabling | 3 |
90 | soccer-training | 2 |
91 | health-coping | 3 |
92 | later-appearing | 1 |
93 | land-sparing | 2 |
94 | nucleoside-sparing | 2 |
95 | cni-sparing | 2 |
96 | surgery-sparing | 7 |
97 | hba1c-lowering | 6 |
98 | bowel-cleansing | 19 |
99 | adenosine-regulating | 1 |
100 | thrombopoietic-stimulating | 1 |
101 | csc-targeting | 1 |
102 | blood-saving | 10 |
103 | laborsaving | 1 |
104 | adherence-modifying | 1 |
105 | 600-microg | 1 |
106 | post-iph | 1 |
107 | human-health | 1 |
108 | non-tki | 2 |
109 | clinical/bacteriological | 2 |
110 | antiretrovirological | 1 |
111 | aesthetic-laser-surgical | 1 |
112 | therapeutical | 251 |
113 | immunotherapeutical | 4 |
114 | review.transcervical | 2 |
115 | photoantimicrobial | 2 |
116 | a.potential | 1 |
117 | less-traditional | 2 |
118 | multi-sectoral | 6 |
119 | 'dual | 4 |
120 | multi-model | 6 |
121 | therapist-level | 2 |
122 | antieosinophil | 1 |
123 | cost-control | 2 |
124 | 400-microgram | 1 |
125 | non-curriculum | 1 |
126 | akt-mammalian | 1 |
127 | pi3k/mammalian | 1 |
128 | akt/mammalian | 2 |
129 | phenotype/syndrome-driven | 1 |
130 | tumor-driven | 3 |
131 | compound-protein | 1 |
132 | 21-min | 1 |
133 | adiponectin/resistin | 1 |
134 | patient-inclusion | 2 |
135 | pain-regulation | 1 |
136 | limited-duration | 2 |
137 | larynx-preservation | 6 |
138 | fertility-preservation | 2 |
139 | cost-reduction | 1 |
140 | caries-inhibition | 2 |
141 | disease-prevention | 5 |
142 | postvention | 4 |
143 | gzo | 1 |
144 | transulnar | 17 |
145 | searched-for | 1 |
146 | patient-counselor | 1 |
147 | capstrep±cis | 1 |
148 | lipid-atherosclerosis | 4 |
149 | 'conscious | 1 |
150 | resource-conscious | 1 |
151 | pka-shift | 2 |
152 | non-psychostimulant | 1 |
153 | hypoxia-relevant | 1 |
154 | intervenient | 2 |
155 | psychiatrist/caregiver/patient | 1 |
156 | blood-management | 1 |
157 | touch/movement | 1 |
158 | disease-treatment | 2 |
159 | combination-treatment | 3 |
160 | prognosis.treatment | 1 |
161 | study.treatment | 1 |
162 | management/treatment | 1 |
163 | safe-transport | 1 |
164 | youth-therapist | 2 |
165 | client-therapist | 3 |
166 | parent-therapist | 3 |
167 | effectsagainst | 1 |
168 | least-cost | 4 |
169 | sublingual/swallow | 1 |
170 | conservation-friendly | 1 |
171 | cell-therapy | 1 |
172 | mechanostimulatory | 1 |
173 | leaders‟ | 1 |
174 | gsα | 1 |